Full Press Release Details
PellePharm Launches With Financing From BridgeBio Pharma To Develop Topical Therapy For Basal Cell Carcinomas And Gorlin Syndrome.
BBIO
PellePharm Launches With Financing From BridgeBio Pharma To Develop Topical Therapy For Basal Cell Carcinomas And Gorlin Syndrome
Key Takeaway: PellePharm Launches With Financing From BridgeBio Pharma To Develop Topical Therapy For Basal Cell Carcinomas And Gorlin Syndrome